»Japanese  
About CBIJ
• What's CBIJ
• Editorial Committee
• About Copyright
Area of Interest
• Area of Interest
Electronic journal
• J-stage Site
Submission
• Instructions
• Submission
Contact us
<About CBIJ>
What's CBI Journal
  CBI Society is active in the interdisciplinary scientific area including chemistry, biology, and informatics with the express goal of seeking solutions to problems with real-world applications such as in drug discovery and personalized medicine.
  CBI journal is a rapidly published on-line journal covering advanced scientific research topics as well as practical methodologies and technologies that are sometimes neglected in the usual scientific journals.
  All papers published in the CBI journal since 2001 are downloadable as pdf files from the J-Stage website ( https://www.jstage.jst.go.jp/  ). Earlier papers published annually from 2001 to 2007 are also available in printed form.
Editorial Committee
Editor in Chief  
    Kaori Fukuzawa Osaka University
Deputy Editor in Chief  
    Teruki Honma RIKEN
    Yukio Tada CBI Office
    Midori Kamimura CBI Research Institute
    Soichi Ogishima Tohoku University, Tohoku Medical Megabank Organization
Area Editors  
  Molecular recognition and molecular modeling
    Takeshi Ishikawa Kagoshima University
    Shigenori Tanaka (Deputy) Kobe University
  In silico drug discovery
    Kaori Fukuzawa Osaka University
  Bioinformatics and its applications in medicine
    Soichi Ogishima Tohoku University, Tohoku Medical Megabank Organization
  Information and computing approach for drug design and ADMET study
    Kiyohiko Sugano Ritsumeikan University
  AI drug discovery
    Teruki Honma RIKEN
  Emerging new technology
    Seiichi Ishida Sojo University
  The new results of the structural biology and related computational technologies of the structural biology
    Midori Kamimura CBI Research Institute
    Takayoshi Kinoshita (Deputy) Osaka Metropolitan University

Editorial Committee Members
    Mitsunori Ikeguchi Yokohama City University
    Kazuyoshi Ikeda RIKEN
    Yoshihiro Uesawa Meiji Pharmaceutical University
    Tsuyoshi Esaki Shiga University
    Mayumi Endo PRISM BioLab Co.,Ltd
    Masateru Ohta RIKEN
    Atsushi Kasuya Daiichi sankyo Limited
    Shinichi Katakura Keio University
    Koichiro Kato Kyushu University
    Mayumi Kamata Kitasato University
    Kohji Kadota The University of Tokyo
    Daisuke Kiga Waseda University
    Keiko Kumazawa TEIJIN PHARMA LIMITED.
    Tomohiro Sato RIKEN
    Masakazu Sekijima Institute of Science Tokyo
    Yuji Takaoka Schrödinger K.K.
    Kazutoshi Takahashi Ajinomoto Co., Inc.
    Hisashi Tadakuma ShanghaiTech University
    Taro Tamada National Institutes for Quantum Science and Technology
    Kei Terayama Yokohama City University
    Mitsuhiro Nakamura Gifu Pharmaceutical University
    Yayoi Natsume NIBIOHN
    Takatsugu Hirokawa University of Tsukuba
    Kazuhiko Fukui Sanyo-Onoda City University
    Shigeki Mitaku Nagoya University (Prof. Emeritus)
    Kaoru Mogushi cBioinformatics
    Kenji Yamagishi Nihon University
    Masayuki Yamamura Institute of Science Tokyo
    Kotaro Yuta In Silico Data, Ltd.
    Tian Yu-Shi Osaka University
    Suyong Re NIBIOHN
    Paul Horton National Cheng Kung University

Advisor
 
    Tsuguchika Kaminuma The Institute for Cyber Academia
    Sun Choi Ewha Womans University
About Copyright
The Chem-Bio Informatics Journal Copyright and License

  All of the authors pledge that the manuscript is original, has not already been published, and is currently under consideration by another journal. And I also agree to the license policy of CC BY 4.0 (Attribution) in the licensed under a Creative Commons Attribution 4.0. The images, videos or other third party material in the article are includes in the article’s Creative Commons.
  The Chem-Bio Informatics Society approves and agrees that all authors reserve the following rights of copyrights on the article, as follows.

  1. Modifying, duplicating, distributing, exhibiting and demonstrating the article.
  2. Specifying that this article is the first public release and re-publishing it.
  3. Making work derived from this article.
  4. Grant other rights such as patents to this article.
  5. Permitting others to use this article.
↑Page top